Evidence map›Paper›PMID 21155910›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2011

Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients.

K Reginald, K Westritschnig, T Werfel, A Heratizadeh, N Novak, M Focke-Tejkl, A M Hirschl, D Y M Leung, O Elisyutina, E Fedenko and 1 more

Abstract read
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. [Dysbalance between the immune system and skin microbiome in chronic inflammatory dermatoses].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Review
  5. Article
  6. The Role of Atopy in COPD and Asthma.Frontiers in medicine · 2021
    Review
  7. Review
  8. Article
  9. Observational
  10. The Role of Immune Defects and Colonization ofAnalytical cellular pathology (Amsterdam) · 2018
    Review
  11. Article
  12. Molecular aspects of allergens in atopic dermatitis.Current opinion in allergy and clinical immunology · 2017
    Review
  13. Article
  14. Review
  15. Article
  16. [Adaptive immune response and associated trigger factors in atopic dermatitis].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2015
    Article
  17. Article
  18. Regulation of Dendritic Cell Function in Inflammation.Journal of immunology research · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

K ReginaldDepartment of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
K Westritschnig
T Werfel
A Heratizadeh
N Novak
M Focke-Tejkl
A M Hirschl
D Y M Leung
O Elisyutina
E Fedenko
R Valenta
Medical University of Vienna · ATInstitute of Immunology and Physiology · RUMedizinische Hochschule Hannover · DEUniversity of Bonn · DEUniversity of Colorado Denver · US

Funding

SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrierU01AI147462 · NIAID · STANFORD UNIVERSITY · PI Mary Johnson, GIDEON LACK · 2020 to 2026
$14.0M
THE ROLE OF BACTERIAL TOXINS IN HUMAN SKIN DISEASER01AR041256 · NIAMS · NATIONAL JEWISH HEALTH · PI GOLEVA, ELENA, LEUNG, DONALD YM · 1992 to 2020
$5.9M
NIAID NIH HHS U01 AI147462NIAMS NIH HHS R01 AR041256NIAMS NIH HHS R01 AR41256
6 · The paper itself

Abstract

backgroundAtopic dermatitis (AD) is a chronic inflammatory skin disease affecting up to 20% children and 9% adults world-wide. AD patients are often sensitized against a broad variety of allergens and more than 90% of them suffer from skin superinfections with Staphylococcus aureus.

objectiveIn this study, we searched for the presence of specific IgE antibodies against S. aureus and Escherichia coli antigens in AD patients.

methodsSera from AD patients (n=79), patients suffering only from allergic rhinoconjunctivitis (n=41) or allergic asthma (n=37) were tested for IgE reactivity to nitrocellulose-blotted S. aureus, E. coli and gut bacterial antigens. IgE-reactive bacterial antigens were affinity purified and identified by mass spectrometry.

resultsMore than 30% of AD patients but not patients suffering only from allergic rhinoconjunctivitis and asthma or non-allergic persons exhibited IgE binding to several protein antigens among them DNA-binding and ribosomal proteins and flagellin. Patients with severe skin manifestations showed more frequently IgE reactivity to S. aureus compared with AD patients with mild symptoms. Positive immediate and late skin test reactions could be induced in sensitized AD patients with S. aureus extract. CONCLUSION AND CLINICAL RELEVANCE: Specific IgE reactivities against a variety of bacterial antigens were observed in a subgroup comprising a third of AD patients and may contribute to allergic inflammation.

Indexed as

AdultAgedAged, 80 and overAntibodies, BacterialAntigens, BacterialDermatitis, AtopicEscherichia coliFemaleHumansImmunoblottingImmunoglobulin EMaleMass SpectrometryMiddle AgedSkin TestsStaphylococcus aureusAntibodies, BacterialAntigens, BacterialImmunoglobulin E

Identifiers

PMID21155910
PMCPMC3057935
OpenAlexW1570415211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.